Table 2

Number and percentage of patients achieving HbA_1c levels ≤ 6.5% and sustaining them (2 or more consecutive values) at ≤ 7%: Intention-to-treat population.

	FOLLOWED BY FAMILY PHYSICIANS				FOLLOWED BY EXPERTS
HbA_1c LEVELS	GLARGINE AND ORAL AGENTS N (%)^*	ORAL AGENTS N (%)^*	HAZARD RATE (95% CI)	P^†	GLARGINE AND ORAL AGENTS N (%)^*	ORAL AGENTS N (%)^*	HAZARD RATE (95% CI)	P^†	P^‡
Sustained at ≤%	27 (20.6)	17 (13.2)	1.69 (0.92–3.09)	.092	11 (14.7)	6 (8.6)	1.74 (0.64–4.69)	.2779	.956
Sustained at ≤%	63 (48.1)	39 (30.2)	1.86 (1.25–2.77)	.002	33 (44.0)	23 (32.9)	1.36 (0.80–2.32)	.2566	.351
First reading ≤%	47 (35.9)	42 (32.6)	1.21 (0.79–1.84)	.38	20 (26.7)	11 (15.7)	1.61 (0.77–3.37)	.2045	.505
First reading ≤%	91 (69.5)	67 (51.9)	1.65 (1.20–2.27)	.002	45 (60.0)	36 (51.4)	1.19 (0.77–1.84)	.4404	.220

HbA_1c—glycated hemoglobin, CI—confidence interval.
↵* N—Actual number of subjects, %—Kaplan-Meier estimated percentage.
↵† Within-arm comparison.
↵‡ Of interaction between family physician and expert care.